CPT code 53220 represents surgical management of malignant tumors of the urethra via partial or complete excision or electrocautery destruction, performed to remove cancerous tissue and improve urinary function. This code captures a focused urologic oncologic procedure that has implications for specialty surgical billing, facility resources, and post-procedure care needs nationwide. Payors commonly involved in coverage and payment for this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical intent and service setting, common modifiers and billing practice context, and national payer considerations. The publication summarizes benchmarks where available, highlights coding and documentation points relevant to reimbursement and utilization, and outlines clinical context including indications and expected sites of service. Data not available in the input are identified explicitly. This resource is intended to support billing professionals, urology providers, and policy analysts in understanding how CPT code 53220 is described, where it is commonly performed, which major payors are relevant, and what topics (benchmarks, policy updates, clinical context) are typically covered in more detailed payer or facility analyses.